Graft Versus Host Disease News and Research

Latest Graft Versus Host Disease News and Research

Scientists seek to improve stem cell transplant outcomes using DNA sequencing, mathematical modeling

Scientists seek to improve stem cell transplant outcomes using DNA sequencing, mathematical modeling

Kiadis Pharma's ATIR product receives EMA's ODD for treatment of acute myeloid leukemia

Kiadis Pharma's ATIR product receives EMA's ODD for treatment of acute myeloid leukemia

Bortezomib drug effective against chronic GVHD

Bortezomib drug effective against chronic GVHD

Cyclophosphamide drug can eliminate life-threatening immune response after bone marrow transplants

Cyclophosphamide drug can eliminate life-threatening immune response after bone marrow transplants

Natural killer cells can be used to combat acute lymphoblastic leukemia

Natural killer cells can be used to combat acute lymphoblastic leukemia

Phase 2 study: Rigel's R348 fails to meet endpoints in patients with dry eye disease

Phase 2 study: Rigel's R348 fails to meet endpoints in patients with dry eye disease

Drug used for treating rheumatoid arthritis can improve health of kidney transplant recipients

Drug used for treating rheumatoid arthritis can improve health of kidney transplant recipients

New collaborative fundraising effort focuses on AYA cancer

New collaborative fundraising effort focuses on AYA cancer

Research demonstrates association between diversity of gut bacteria and survival

Research demonstrates association between diversity of gut bacteria and survival

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck's NOXAFIL injection gets FDA approval for intravenous use

Researcher to receive AACR- Joseph H. Burchenal Memorial Award for achievement in cancer research

Researcher to receive AACR- Joseph H. Burchenal Memorial Award for achievement in cancer research

FDA approves Miltenyi Biotec's CliniMACS CD34 Reagent System for prevention of GVHD

FDA approves Miltenyi Biotec's CliniMACS CD34 Reagent System for prevention of GVHD

New reports demonstrate the effectiveness of modified T cells in treating blood-borne cancers

New reports demonstrate the effectiveness of modified T cells in treating blood-borne cancers

Immunologists receive $4.8M grant to target multiple diseases by manipulating enzyme

Immunologists receive $4.8M grant to target multiple diseases by manipulating enzyme

Genetically engineered cell therapies demonstrate early efficacy, safety in patients with blood disorders

Genetically engineered cell therapies demonstrate early efficacy, safety in patients with blood disorders

Bortezomib reduces GVHD, boosts survival for patients receiving stem-cell transplants

Bortezomib reduces GVHD, boosts survival for patients receiving stem-cell transplants

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck announces approval of NOXAFIL delayed-release tablets by FDA

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

FDA accepts Merck's NOXAFIL IV solution NDA for priority review